metaproterenol has been researched along with Lung Neoplasms in 10 studies
Metaproterenol: A beta-2 adrenergic agonist used in the treatment of ASTHMA and BRONCHIAL SPASM.
orciprenaline : A racemate composed of equimolar amounts of (R)- and (S)-orciprenaline. Used (as its sulfate salt) to relax the airway muscles and improve breathing for patients suffering from asthma or bronchitis.
5-[1-hydroxy-2-(isopropanylamino)ethyl]benzene-1,3-diol : A member of the class of resorcinols bearing an additional 1-hydroxy-2-(isopropanylamino)ethyl substituent at position 5 of resorcinol itself.
Lung Neoplasms: Tumors or cancer of the LUNG.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Resistance to metastasis was assessed under baseline conditions and following the administration of a beta-adrenergic agonist, metaproterenol (MP)." | 1.31 | The effects of a Chinese herb formula, anti-cancer number one (ACNO), on NK cell activity and tumor metastasis in rats. ( Ben-Eliyahu, S; Hong-Fen, L; Maimon, Y; Rosenne, E; Shakhar, K; Waisman, T, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (30.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Levi, B | 1 |
| Benish, M | 1 |
| Goldfarb, Y | 1 |
| Sorski, L | 1 |
| Melamed, R | 2 |
| Rosenne, E | 2 |
| Ben-Eliyahu, S | 7 |
| Page, GG | 3 |
| Fennelly, AM | 1 |
| Littleton-Kearney, MT | 1 |
| Adamoli, S | 1 |
| Henriquet, F | 1 |
| Kanisawa, M | 1 |
| Shakhar, G | 3 |
| Shakhar, K | 3 |
| Stefanski, V | 1 |
| Hong-Fen, L | 1 |
| Waisman, T | 1 |
| Maimon, Y | 1 |
| Jaworski, A | 1 |
| Goldberg, SK | 1 |
| Walkenstein, MD | 1 |
| Wilson, B | 1 |
| Lippmann, ML | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Assessment of Influence of Routine Postoperative Systematic Bronchial Aspiration With Flexible Bronchoscope on Occurrence of Pulmonary Complications After Anatomical Lung Resections: a Prospective Randomized Controlled Study.[NCT03307018] | 200 participants (Anticipated) | Interventional | 2021-04-08 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for metaproterenol and Lung Neoplasms
| Article | Year |
|---|---|
Utility of immediate postlobectomy fiberoptic bronchoscopy in preventing atelectasis.
Topics: Administration, Inhalation; Bronchoscopes; Clinical Trials as Topic; Female; Fiber Optic Technology; | 1988 |
9 other studies available for metaproterenol and Lung Neoplasms
| Article | Year |
|---|---|
Continuous stress disrupts immunostimulatory effects of IL-12.
Topics: Adenocarcinoma; Adjuvants, Immunologic; Adrenergic beta-2 Receptor Agonists; Analysis of Variance; A | 2011 |
Male--female differences in the impact of beta-adrenoceptor stimulation on resistance to experimental metastasis: exploring the effects of age and gonadal hormone involvement.
Topics: Age Factors; Animals; Cell Line, Tumor; Epinephrine; Female; Gonadal Steroid Hormones; Killer Cells, | 2008 |
[The preoperative preparation in thoracic surgery with the use of intermittent positive and negative pressure respiration combined with a bronchodilator agent].
Topics: Adult; Aged; Cysts; Female; Humans; Lung Diseases; Lung Neoplasms; Male; Metaproterenol; Middle Aged | 1967 |
[Pathogenesis of human cancer development due to environmental factors].
Topics: Adult; Aflatoxin B1; Aflatoxins; Animals; Bronchi; Carcinogens; Carcinoma, Hepatocellular; Carcinoma | 1984 |
In vivo beta-adrenergic stimulation suppresses natural killer activity and compromises resistance to tumor metastasis in rats.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Blood-Brain Barrier; Cytotoxicity, I | 1998 |
Natural killer cell activity and resistance to tumor metastasis in prepubescent rats: deficient baselines, but invulnerability to stress and beta-adrenergic stimulation.
Topics: Adrenergic beta-Agonists; Aging; Animals; Corticosterone; Cytotoxicity, Immunologic; Female; Hypotha | 2000 |
Timing within the oestrous cycle modulates adrenergic suppression of NK activity and resistance to metastasis: possible clinical implications.
Topics: Adrenergic beta-Agonists; Animals; Cytotoxicity, Immunologic; Dose-Response Relationship, Drug; Estr | 2000 |
Suppression of NK cell activity and of resistance to metastasis by stress: a role for adrenal catecholamines and beta-adrenoceptors.
Topics: Adrenal Medulla; Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-2 Receptor Antagonists; Ani | 2000 |
The effects of a Chinese herb formula, anti-cancer number one (ACNO), on NK cell activity and tumor metastasis in rats.
Topics: Adenocarcinoma; Adrenergic beta-Agonists; Animals; Antineoplastic Agents, Phytogenic; Cell Count; Cy | 2001 |